MedTrace Logo

EEG Studies of IV Methylphenidate-Induced Emergence From Anesthesia

NCT02429076 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2017-08-02

No results posted yet for this study

Summary

The aim of this study is to test the hypothesis that methylphenidate actively induces emergence from propofol and sevoflurane general anesthesia in healthy volunteers.

Conditions

  • Active Emergence From General Anesthesia

Interventions

DRUG

IV methylphenidate

IV methylphenidate will be administered to induce emergence from general anesthesia.

DRUG

Placebo

normal saline

DRUG

Sevoflurane

Inhaled anesthetic

DRUG

Propofol

IV anesthetic

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
36 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2019-07-31
Completion
2019-12-31
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02429076 on ClinicalTrials.gov